Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia: letters to the editor

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jaramillo Segura, Sonia (VerfasserIn) , Krisam, Johannes (VerfasserIn) , Le Cornet, Lucian (VerfasserIn) , Kratzmann, Markus (VerfasserIn) , Baumann, Lukas (VerfasserIn) , Eissymont, Olga (VerfasserIn) , Crysandt, Martina (VerfasserIn) , Görner, Martin (VerfasserIn) , Kayser, Sabine (VerfasserIn) , Krause, Stefan W. (VerfasserIn) , Schliemann, Christoph (VerfasserIn) , Gaska, Tobias (VerfasserIn) , Kaufmann, Martin (VerfasserIn) , Chemnitz, Jens (VerfasserIn) , Schaich, Markus (VerfasserIn) , Hoellein, Alexander (VerfasserIn) , Platzbecker, Uwe (VerfasserIn) , Kieser, Meinhard (VerfasserIn) , Müller-Tidow, Carsten (VerfasserIn) , Schlenk, Richard Friedrich (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: June, 2024
In: Haematologica
Year: 2024, Jahrgang: 109, Heft: 6, Pages: 1973-1976
ISSN:1592-8721
DOI:10.3324/haematol.2023.284346
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3324/haematol.2023.284346
Verlag, kostenfrei, Volltext: https://haematologica.org/article/view/haematol.2023.284346
Volltext
Verfasserangaben:Sonia Jaramillo, Johannes Krisam, Lucian Le Cornet, Markus Kratzmann, Lukas Baumann, Olga Eissymont, Martina Crysandt, Martin Görner, Sabine Kayser, Stefan Krause, Christoph Schliemann, Tobias Gaska, Martin Kaufmann, Jens Chemnitz, Markus Schaich, Alexander Hoellein, Uwe Platzbecker, Meinhard Kieser, Carsten Müller-Tidow and Richard F. Schlenk

MARC

LEADER 00000caa a2200000 c 4500
001 1917443900
003 DE-627
005 20250716232420.0
007 cr uuu---uuuuu
008 250218s2024 xx |||||o 00| ||eng c
024 7 |a 10.3324/haematol.2023.284346  |2 doi 
035 |a (DE-627)1917443900 
035 |a (DE-599)KXP1917443900 
035 |a (OCoLC)1528019343 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Jaramillo Segura, Sonia  |e VerfasserIn  |0 (DE-588)1149855606  |0 (DE-627)1010162772  |0 (DE-576)496412213  |4 aut 
245 1 0 |a Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia  |b letters to the editor  |c Sonia Jaramillo, Johannes Krisam, Lucian Le Cornet, Markus Kratzmann, Lukas Baumann, Olga Eissymont, Martina Crysandt, Martin Görner, Sabine Kayser, Stefan Krause, Christoph Schliemann, Tobias Gaska, Martin Kaufmann, Jens Chemnitz, Markus Schaich, Alexander Hoellein, Uwe Platzbecker, Meinhard Kieser, Carsten Müller-Tidow and Richard F. Schlenk 
264 1 |c June, 2024 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 18.02.2025 
700 1 |a Krisam, Johannes  |d 1986-  |e VerfasserIn  |0 (DE-588)1016031343  |0 (DE-627)705475034  |0 (DE-576)351438696  |4 aut 
700 1 |a Le Cornet, Lucian  |e VerfasserIn  |0 (DE-588)1210096501  |0 (DE-627)1698161700  |4 aut 
700 1 |a Kratzmann, Markus  |e VerfasserIn  |4 aut 
700 1 |a Baumann, Lukas  |d 1991-  |e VerfasserIn  |0 (DE-588)1247739481  |0 (DE-627)1782338802  |4 aut 
700 1 |a Eissymont, Olga  |e VerfasserIn  |0 (DE-588)1356661130  |0 (DE-627)1917445717  |4 aut 
700 1 |a Crysandt, Martina  |d 1979-  |e VerfasserIn  |0 (DE-588)136441173  |0 (DE-627)583290523  |0 (DE-576)301021988  |4 aut 
700 1 |a Görner, Martin  |e VerfasserIn  |4 aut 
700 1 |a Kayser, Sabine  |d 1979-  |e VerfasserIn  |0 (DE-588)138694923  |0 (DE-627)605256233  |0 (DE-576)30778813X  |4 aut 
700 1 |a Krause, Stefan W.  |d 1959-  |e VerfasserIn  |0 (DE-588)124439565X  |0 (DE-627)1775638367  |4 aut 
700 1 |a Schliemann, Christoph  |e VerfasserIn  |4 aut 
700 1 |a Gaska, Tobias  |e VerfasserIn  |4 aut 
700 1 |a Kaufmann, Martin  |e VerfasserIn  |4 aut 
700 1 |a Chemnitz, Jens  |e VerfasserIn  |4 aut 
700 1 |a Schaich, Markus  |e VerfasserIn  |0 (DE-588)1111909857  |0 (DE-627)865957487  |0 (DE-576)476317320  |4 aut 
700 1 |a Hoellein, Alexander  |e VerfasserIn  |4 aut 
700 1 |a Platzbecker, Uwe  |e VerfasserIn  |0 (DE-588)115567089  |0 (DE-627)647686228  |0 (DE-576)337938695  |4 aut 
700 1 |a Kieser, Meinhard  |d 1960-  |e VerfasserIn  |0 (DE-588)103276547X  |0 (DE-627)739277766  |0 (DE-576)168963825  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Schlenk, Richard Friedrich  |d 1965-  |e VerfasserIn  |0 (DE-588)129025380  |0 (DE-627)387778004  |0 (DE-576)297454102  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica  |d Pavia : Ferrata Storti Foundation, 2014  |g 109(2024), 6 vom: Juni, Seite 1973-1976  |h Online-Ressource  |w (DE-627)814204899  |w (DE-600)2805244-4  |w (DE-576)424051125  |x 1592-8721  |7 nnas  |a Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia letters to the editor 
773 1 8 |g volume:109  |g year:2024  |g number:6  |g month:06  |g pages:1973-1976  |g extent:4  |a Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia letters to the editor 
856 4 0 |u https://doi.org/10.3324/haematol.2023.284346  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://haematologica.org/article/view/haematol.2023.284346  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250218 
993 |a Editorial 
994 |a 2024 
998 |g 129025380  |a Schlenk, Richard Friedrich  |m 129025380:Schlenk, Richard Friedrich  |d 910000  |d 910100  |e 910000PS129025380  |e 910100PS129025380  |k 0/910000/  |k 1/910000/910100/  |p 20  |y j 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 19 
998 |g 103276547X  |a Kieser, Meinhard  |m 103276547X:Kieser, Meinhard  |d 910000  |d 911800  |e 910000PK103276547X  |e 911800PK103276547X  |k 0/910000/  |k 1/910000/911800/  |p 18 
998 |g 138694923  |a Kayser, Sabine  |m 138694923:Kayser, Sabine  |d 60000  |d 63500  |e 60000PK138694923  |e 63500PK138694923  |k 0/60000/  |k 1/60000/63500/  |p 9 
998 |g 1356661130  |a Eissymont, Olga  |m 1356661130:Eissymont, Olga  |d 50000  |e 50000PE1356661130  |k 0/50000/  |p 6 
998 |g 1247739481  |a Baumann, Lukas  |m 1247739481:Baumann, Lukas  |d 910000  |d 911800  |e 910000PB1247739481  |e 911800PB1247739481  |k 0/910000/  |k 1/910000/911800/  |p 5 
999 |a KXP-PPN1917443900  |e 4665524998 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1917443900","physDesc":[{"extent":"4 S."}],"title":[{"title_sort":"Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia","title":"Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia","subtitle":"letters to the editor"}],"note":["Gesehen am 18.02.2025"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"relHost":[{"titleAlt":[{"title":"journal of the European Hematology Association"}],"pubHistory":["99.2014 -"],"id":{"zdb":["2805244-4"],"issn":["1592-8721"],"eki":["814204899"]},"part":{"year":"2024","volume":"109","pages":"1973-1976","extent":"4","text":"109(2024), 6 vom: Juni, Seite 1973-1976","issue":"6"},"recId":"814204899","physDesc":[{"extent":"Online-Ressource"}],"disp":"Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia letters to the editorHaematologica","origin":[{"publisher":"Ferrata Storti Foundation","publisherPlace":"Pavia","dateIssuedKey":"2014","dateIssuedDisp":"2014-"}],"title":[{"title_sort":"Haematologica","title":"Haematologica","subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 27.05.2022"]}],"person":[{"display":"Jaramillo Segura, Sonia","given":"Sonia","role":"aut","family":"Jaramillo Segura"},{"display":"Krisam, Johannes","given":"Johannes","role":"aut","family":"Krisam"},{"display":"Le Cornet, Lucian","role":"aut","given":"Lucian","family":"Le Cornet"},{"family":"Kratzmann","given":"Markus","role":"aut","display":"Kratzmann, Markus"},{"display":"Baumann, Lukas","family":"Baumann","given":"Lukas","role":"aut"},{"display":"Eissymont, Olga","role":"aut","given":"Olga","family":"Eissymont"},{"given":"Martina","role":"aut","family":"Crysandt","display":"Crysandt, Martina"},{"family":"Görner","given":"Martin","role":"aut","display":"Görner, Martin"},{"display":"Kayser, Sabine","family":"Kayser","role":"aut","given":"Sabine"},{"display":"Krause, Stefan W.","family":"Krause","given":"Stefan W.","role":"aut"},{"display":"Schliemann, Christoph","role":"aut","given":"Christoph","family":"Schliemann"},{"family":"Gaska","role":"aut","given":"Tobias","display":"Gaska, Tobias"},{"family":"Kaufmann","given":"Martin","role":"aut","display":"Kaufmann, Martin"},{"family":"Chemnitz","role":"aut","given":"Jens","display":"Chemnitz, Jens"},{"display":"Schaich, Markus","role":"aut","given":"Markus","family":"Schaich"},{"family":"Hoellein","given":"Alexander","role":"aut","display":"Hoellein, Alexander"},{"given":"Uwe","role":"aut","family":"Platzbecker","display":"Platzbecker, Uwe"},{"family":"Kieser","role":"aut","given":"Meinhard","display":"Kieser, Meinhard"},{"display":"Müller-Tidow, Carsten","given":"Carsten","role":"aut","family":"Müller-Tidow"},{"display":"Schlenk, Richard Friedrich","role":"aut","given":"Richard Friedrich","family":"Schlenk"}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"June, 2024"}],"id":{"doi":["10.3324/haematol.2023.284346"],"eki":["1917443900"]},"name":{"displayForm":["Sonia Jaramillo, Johannes Krisam, Lucian Le Cornet, Markus Kratzmann, Lukas Baumann, Olga Eissymont, Martina Crysandt, Martin Görner, Sabine Kayser, Stefan Krause, Christoph Schliemann, Tobias Gaska, Martin Kaufmann, Jens Chemnitz, Markus Schaich, Alexander Hoellein, Uwe Platzbecker, Meinhard Kieser, Carsten Müller-Tidow and Richard F. Schlenk"]}} 
SRT |a JARAMILLOSRANDOMIZED2024